(Q41712984)

English

Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous p

scientific article published on December 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous p (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

0 references

author name string

Brooks B

1

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Chapman K

2

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Lawry J

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Meager A

4

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Rees RC

5

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

publication date

1 December 1990

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

583-589

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Evidence for IL-2 independent proliferation in human T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor beta 1 (TGF-beta 1) receptor expression on resting and mitogen-activated T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of cancer using interleukin 2: current status and future prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of interferon alpha and gamma, singly or in combination on human natural cell mediated cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 enhances the induction of human lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of human colorectal adenocarcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 enhances natural killer cell activity through induction of gamma interferon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of lymphokine-activated killer cells does not require DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-signal requirement for interferon-gamma production by human large granular lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and modulation of the cellular receptor for transforming growth factor-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 activated human killer lymphocytes: lack of involvement of interferon in the development of IL-2-activated killer lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human T cells from autoimmune and normal individuals can produce tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TG

1 reference

https://pubmed.ncbi.nlm.nih.gov/2124961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.1990.TB05494.X

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41712984&oldid=1541067810"